Target ID:Tar13
ID:T86552
Target Name:Tumor necrosis factor receptor type I (TNF-R1)
Target Type:Protein
CID:--
URL:https://db.idrblab.net/ttd/data/target/details/T86552
Related Drugs:--

Knowledge Graph

Drug IDDrug NameTypeDrugBank IDTargetsCategoryLatest Progress
No data available

Evaluation of inflammatory bowel disease activity in children using serum trefo…

PMID: 32120375
Year: 2020
Relationship Type: Mechanism Investigation Score: 6.2

Inflammatory bowel disease (IBD), including ulcerative colitis (UC) and Crohn's disease (CD), is a class of severe and chronic diseases of the gastr…

A Systematic Review on Cost-effectiveness Analyses of Therapeutic Drug Monitori…

PMID: 32311018
Year: 2021
Relationship Type: Mechanism Investigation Score: 5.9

Morbidity of inflammatory gastrointestinal (GI) diseases continues to grow resulting in worsen quality of life and increased burden on public medica…

Flavokawain B inhibits NF-κB inflammatory signaling pathway activation in infla…

PMID: 38583725
Year: 2024
Relationship Type: Mechanism Investigation Score: 5.5

Inflammatory bowel disease (IBD) is characterized by recurrent inflammatory reactions in the intestinal mucosa, including ulcerative colitis (UC) and…

ATF3 restoration as a potential strategy in managing ulcerative colitis: Implic…

PMID: 40318535
Year: 2025
Relationship Type: Target Validation Score: 5.5

BACKGROUND: Ulcerative colitis (UC) is a chronic inflammatory bowel disease with limited therapeutic options, particularly for moderate-to-severe cas…

Coordination of ENT2-dependent adenosine transport and signaling dampens mucosa…

PMID: 30333323
Year: 2018
Relationship Type: Mechanism Investigation Score: 5.5

Downregulation of P-glycoprotein (P-gp) is implicated in the pathophysiology of inflammatory bowel disease (IBD). Berberine, a principal isoquinolin…

Recent advances in the treatment of IBD: Targets, mechanisms and related therap…

PMID: 37455149
Year: 2023
Relationship Type: Mechanism Investigation Score: 5.4

Inflammatory bowel disease (IBD), as a representative inflammatory disease, currently has multiple effective treatment options available and new ther…

Direct inhibition of the TXNIP-NLRP3-GSDMD pathway reduces pyroptosis in colono…

PMID: 40195510
Year: 2025
Relationship Type: Mechanism Investigation Score: 5.3

Ulcerative colitis (UC) is a chronic inflammatory bowel disease. The etiology of UC is multifaceted, and the underlying pathogenesis remains incomple…

Signaling pathways induced by serine proteases to increase intestinal epithelia…

PMID: 28671992
Year: 2017
Relationship Type: Mechanism Investigation Score: 5.3

Changes in barrier function of the gastrointestinal tract are thought to contribute to the inflammatory bowel diseases Crohn's disease and ulcerative…

The San-Qi-Xue-Shang-Ning formula protects against ulcerative colitis by restor…

PMID: 36603786
Year: 2023
Relationship Type: Mechanism Investigation Score: 5.3

ETHNOPHARMACOLOGICAL RELEVANCE: Ulcerative colitis (UC) is a major cause of morbidity and mortality due to repetitive remissions and relapses, and ma…

Real-world Experience of Anti-tumor Necrosis Factor Therapy for Internal Fistul…

PMID: 29084079
Year: 2017
Relationship Type: Mechanism Investigation Score: 5.3

In Crohn's disease, pathogenic Th17-cells express low levels of CD39 ectonucleotidase and are refractory to the immunosuppressive effects of unconj…

Role of tumor necrosis factor-α in the extraintestinal thrombosis associated wi…

PMID: 21987296
Year: 2011
Relationship Type: Mechanism Investigation Score: 5.3

Therapeutic intervention in inflammatory bowel diseases (IBDs) is often associated with adverse effects related to drug distribution into non-diseas…

Up-regulation and cytoprotective role of epithelial multidrug resistance-associ…

PMID: 18838379
Year: 2008
Relationship Type: Mechanism Investigation Score: 5.3

Tumor necrosis factor (TNF) is key to the pathogenesis of various arthritic diseases and inflammatory bowel disease (IBD). Anti-TNF therapies have p…

Tumor Necrosis Factor-Like Ligand 1A/Death Receptor 3 Signaling Regulates the G…

PMID: 40204100
Year: 2025
Relationship Type: Mechanism Investigation Score: 5.2

BACKGROUND & AIMS: Death receptor 3 (DR3) and its ligand, tumor necrosis factor-like ligand 1A (TL1A), regulate the balance between effector and regu…

Activation of mucosal insulin receptor exacerbates intestinal inflammation by p…

PMID: 38243324
Year: 2024
Relationship Type: Mechanism Investigation Score: 5.2

BACKGROUND: Inflammatory Bowel Diseases (IBD), an autoimmune disease characterised by abnormal intestinal immunity, are related to vital morbidity ar…

The potential mechanism of Bletilla striata in the treatment of ulcerative coli…

PMID: 36576506
Year: 2023
Relationship Type: Target Validation Score: 5.2

Ulcerative colitis (UC) is a chronic nonspecific intestinal inflammatory disease, which belongs to a subtype of inflammatory bowel disease, but still…

The pharmacological validation of the Xiao-Jian-Zhong formula against ulcerativ…

PMID: 35987415
Year: 2022
Relationship Type: Target Validation Score: 5.2

ETHNOPHARMACOLOGICAL RELEVANCE: Inflammatory bowel disease (IBD) is pathologically characterized by an immune response accommodative insufficiency an…

The deubiquitinase OTUD1 inhibits colonic inflammation by suppressing RIPK1-med…

PMID: 34876703
Year: 2022
Relationship Type: Mechanism Investigation Score: 5.2

BACKGROUND & AIMS: Although interactions between enteric glial cells (EGCs) and enteric mast cells have been demonstrated to play an important role …

Hemophagocytic Lymphohistiocytosis and Inflammatory Bowel Disease: Case Report …

PMID: 32596254
Year: 2020
Relationship Type: Mechanism Investigation Score: 5.2

The peroxisome proliferator-activated receptors (PPARs) are a group of nuclear receptor proteins that promote ligand-dependent transcription of targ…

PTPN22 regulates NLRP3-mediated IL1B secretion in an autophagy-dependent manner

PMID: 28786745
Year: 2017
Relationship Type: Mechanism Investigation Score: 5.2

A variant within the gene locus encoding PTPN22 (protein tyrosine phosphatase, non-receptor type 22) emerged as an important risk factor for auto-inf…

Signal termination of the chemokine receptor CCR9 is governed by an arrestin-in…

PMID: 40154615
Year: 2025
Relationship Type: Mechanism Investigation Score: 5.1

The C-C chemokine receptor type 9 (CCR9) coordinates immune cell migration from the thymus to the small intestine along gradients of the chemokine CC…

Candidate IDSource IDSource TypeCompound TypeCandidate NameInclusion Criteria
No data available

Compound IDSource IDSource TypeCompound NameMolecular WeightMolecular FormulaMolecular Species
bio26864 CHEMBL48361 Small molecule DABIGATRAN 471.52 C25H25N7O3 ZWITTERION Details
bio26865 CHEMBL3975522 Small molecule EBOPIPRANT 599.75 C30H34FN3O5S2 NEUTRAL Details
bio26866 CHEMBL2103920 Protein ULARITIDE 3505.99 C145H234N52O44S3 -- Details
bio26867 CHEMBL2354444 Small molecule PIRARUBICIN 627.64 C32H37NO12 BASE Details
bio26868 CHEMBL1200399 Small molecule BUSPIRONE HYDROCHLORIDE 421.97 C21H32ClN5O2 NEUTRAL Details
bio26869 CHEMBL2107261 Small molecule TOLPROPAMINE 253.39 C18H23N BASE Details
bio26870 CHEMBL603 Small molecule ZAFIRLUKAST 575.69 C31H33N3O6S ACID Details
bio26871 CHEMBL3545408 Small molecule NALTALIMIDE 472.54 C28H28N2O5 BASE Details
bio26872 CHEMBL2110367 Small molecule TRIMETHOPRIM SULFATE 678.73 C28H38N8O10S NEUTRAL Details
bio26873 CHEMBL2105401 Small molecule TIOCLOMAROL 447.34 C22H16Cl2O4S ACID Details

Strategy IDTherapy StrategySynonymsRelated DrugsMechanism
No data available